These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 28118372)
1. Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China. Sun Y; Harley D; Vally H; Sleigh A PLoS One; 2017; 12(1):e0168865. PubMed ID: 28118372 [TBL] [Abstract][Full Text] [Related]
2. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China. Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894 [TBL] [Abstract][Full Text] [Related]
3. Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study. Huai P; Huang X; Cheng J; Zhang C; Wang K; Wang X; Yang L; Deng Z; Ma W Microb Drug Resist; 2016 Dec; 22(8):717-726. PubMed ID: 27058017 [TBL] [Abstract][Full Text] [Related]
4. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis. Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
6. [Impact of anti-tuberculosis drug resistance on treatment outcome of pulmonary tuberculosis patients receiving directly observed treatment strategy in Henan Province, China]. Wang GJ; Xu JY; Wang GB; Zhen XA; Gao SY; Du CM Zhonghua Jie He He Hu Xi Za Zhi; 2006 Aug; 29(8):527-30. PubMed ID: 17074265 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Jiao WW; Liu ZG; Han R; Zhao XQ; Dong F; Dong HY; Huang HR; Li QJ; Lin N; Song WQ; Wan KL; Shen AD Tuberculosis (Edinb); 2015 May; 95(3):315-20. PubMed ID: 25814302 [TBL] [Abstract][Full Text] [Related]
8. Drug resistance and epidemiology characteristics of multidrug-resistant tuberculosis patients in 17 provinces of China. Lu Z; Jiang W; Zhang J; Lynn HS; Chen Y; Zhang S; Ma Z; Geng P; Guo X; Zhang H; Zhang Z PLoS One; 2019; 14(11):e0225361. PubMed ID: 31751390 [TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis: treatment outcome in Denmark, 1992-2007. Bang D; Lillebaek T; Thomsen VØ; Andersen AB Scand J Infect Dis; 2010 Apr; 42(4):288-93. PubMed ID: 20082573 [TBL] [Abstract][Full Text] [Related]
10. Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis. Kempker RR; Kipiani M; Mirtskhulava V; Tukvadze N; Magee MJ; Blumberg HM Emerg Infect Dis; 2015 Jun; 21(6):992-1001. PubMed ID: 25993036 [TBL] [Abstract][Full Text] [Related]
11. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China]. Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331 [TBL] [Abstract][Full Text] [Related]
12. The burden of MDR/XDR tuberculosis in coastal plains population of China. Yang X; Yuan Y; Pang Y; Wang B; Bai Y; Wang Y; Yu B; Zhang Z; Fan M; Zhao Y PLoS One; 2015; 10(2):e0117361. PubMed ID: 25689373 [TBL] [Abstract][Full Text] [Related]
13. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823 [TBL] [Abstract][Full Text] [Related]
14. [The long term (9-year) survival of multidrug-resistant tuberculosis patients compared to non-multidrug-resistant tuberculosis patients in Henan province]. Sun YN; Wang GJ; Zhen XA; Liu ZF; Harley D; Hall G; Vally H; Sleigh A Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):133-6. PubMed ID: 23751466 [TBL] [Abstract][Full Text] [Related]
15. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance. Jaber AAS; Ibrahim B BMC Infect Dis; 2019 May; 19(1):464. PubMed ID: 31126246 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Hu Y; Mathema B; Wang W; Hoffner S; Kreiswirth B; Xu B Microb Drug Resist; 2008 Sep; 14(3):227-32. PubMed ID: 18707239 [TBL] [Abstract][Full Text] [Related]
18. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China. Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458 [TBL] [Abstract][Full Text] [Related]
19. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design. Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290 [TBL] [Abstract][Full Text] [Related]
20. Recurrence after Successful Treatment of Multidrug-Resistant Tuberculosis in Taiwan. Chen MY; Lo YC; Chen WC; Wang KF; Chan PC PLoS One; 2017; 12(1):e0170980. PubMed ID: 28125692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]